Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000039624Phase 4Recruiting
Phase 4, open-label trial of alfentanil and propofol in None (4 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoint: Success rate of induction for the first time. Started Nov 2020; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000039624.